At close: May 14, 5:00 PM EST
$0.1500
-0.0276-15.54%
After Hours: Jun 12, 8:00 AM EST
SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. Earnings Estimates
SGMOOTCQB
SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. Earnings Estimates, EPS & Revenue | OTC:SGMO
SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. (SGMO) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.04 and quarterly revenue of $6.40M.
In the most recent quarter (Q1), SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. reported EPS of $-0.08, missing estimates of $-0.06 by 0.33%. Revenue came in at $1.44M, missing the estimate of $28.88M by 0.95%.
SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. has missed EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. has averaged an EPS surprise of 1.40% and a revenue surprise of 0.72%.
Earnings Date
Aug 6
EPS Estimate
$-0.040
Quarterly Revenue Estimate
$6.40M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$34.56M
SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. Earnings History
Analyze the earnings history of SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. using advanced sorting and filters.
Loading calendar...
SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. (SGMO) Earnings Per Share
The chart below shows SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc.'s reported EPS compared to analyst estimates over recent quarters.
SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. (SGMO) Revenue
The chart below shows SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc.'s reported revenue compared to analyst estimates over recent quarters.
FAQ
When is SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. (OTCQB:SGMO) reporting earnings?
SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. (SGMO) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc. (OTCQB:SGMO)?
The Actual EPS was $-0.08, which missed the estimate of $-0.06.
What were SANGAMO THERAPEUTICS INC by Sangamo Therapeutics, Inc.’s (OTCQB:SGMO) revenues?
The Actual Revenue was $1.44M, which missed the estimate of $28.88M.
